pubmed-article:10493962 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10493962 | lifeskim:mentions | umls-concept:C0040083 | lld:lifeskim |
pubmed-article:10493962 | lifeskim:mentions | umls-concept:C0476089 | lld:lifeskim |
pubmed-article:10493962 | lifeskim:mentions | umls-concept:C0302600 | lld:lifeskim |
pubmed-article:10493962 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10493962 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10493962 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10493962 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:10493962 | pubmed:dateCreated | 1999-11-24 | lld:pubmed |
pubmed-article:10493962 | pubmed:abstractText | The object of this study was to clarify the association of angiogenic factor, platelet-derived endothelial cell growth factor (PD-ECGF)/thymidine phosphorylase (dThdPase) with clinicopathological factors including tumor angiogenesis and patient outcome in endometrial cancer. There was no correlation between the expression of PD-ECGF in cancer cells and any of the clinicopathological variables. Immunopositivity for PD-ECGF in stroma cells was significantly higher in poorly differentiated adenocarcinomas. The microvessel counts correlated with PD-ECGF positive stroma cells (p<0.0001). Disease-free survival was significantly worse in patients with marked PD-ECGF expression in stromal cells and high microvessel count. A multivariate analysis using Cox's proportional hazard model showed that high microvessel counts independently predicted disease-free survival as well as stage and myometrial invasion. The expression of PD-ECGF in stroma cells may play a crucial role in the promotion of angiogenesis. Tumor angiogenesis can be used to predict prognosis in patients with endometrial cancer. | lld:pubmed |
pubmed-article:10493962 | pubmed:language | eng | lld:pubmed |
pubmed-article:10493962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10493962 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10493962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10493962 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10493962 | pubmed:month | Oct | lld:pubmed |
pubmed-article:10493962 | pubmed:issn | 1019-6439 | lld:pubmed |
pubmed-article:10493962 | pubmed:author | pubmed-author:KudoTT | lld:pubmed |
pubmed-article:10493962 | pubmed:author | pubmed-author:MiyagiYY | lld:pubmed |
pubmed-article:10493962 | pubmed:author | pubmed-author:KodamaJJ | lld:pubmed |
pubmed-article:10493962 | pubmed:author | pubmed-author:RANNE LEL | lld:pubmed |
pubmed-article:10493962 | pubmed:author | pubmed-author:YoshinouchiMM | lld:pubmed |
pubmed-article:10493962 | pubmed:author | pubmed-author:HongoAA | lld:pubmed |
pubmed-article:10493962 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10493962 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:10493962 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10493962 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10493962 | pubmed:pagination | 781-6 | lld:pubmed |
pubmed-article:10493962 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:meshHeading | pubmed-meshheading:10493962... | lld:pubmed |
pubmed-article:10493962 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10493962 | pubmed:articleTitle | Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in endometrial cancer. | lld:pubmed |
pubmed-article:10493962 | pubmed:affiliation | Department of Obstetrics and Gynecology, Okayama University Medical School, Okayama 700-8558, Japan. | lld:pubmed |
pubmed-article:10493962 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10493962 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10493962 | lld:pubmed |